The Latest Breaking News from Psoriasis

It's can be a psoriasis savior—when used sparingly.

Ventyx Biosciences scrapped a psoriasis drug that didn't pass muster in Phase 2 testing on Tuesday, and VTYX stock crashed more than 80%.

New research on the connection between severe psoriasis and coronary microvascular dysfunction suggested that those with severe psoriasis have a higher risk of cardiovascular disease.ad further on Dynamite News:

It’s more than ‘just’ dry skin

Researchers created and validated a tool called PRESTO that identifies psoriasis patients who have a higher chance of developing psoriatic arthritis and may therefore benefit from preventative medications. Read further on Dynamite News:

Doctors talk through the symptoms, causes and treatments of this skin condition. By Katie Wright.

The products can also be used to treat skin conditions such as; eczema, psoriasis and ichthyosis

Topical corticosteroids, also referred to as corticosteroids or cortisone, are the go-to treatment for many skin disorders including eczema, dermatitis and psoriasis. They can be found in various forms such as creams, ointments, and solutions.

Shares of PTGX stock briefly broke out Friday after Protagonist said it plans to soon present new test results for its psoriasis drug.

According to a study by UC Davis Health researchers, inflammatory skin conditions like psoriasis may be caused by a Western diet saturated high in fat and sugar. Read further on Dynamite News:

Ellie Douglass, 18, was bullied all through school because of her skin and often skipped classes, leaving her with just one GCSE